Rhenman & Partners Asset Management Ab Dexcom Inc Transaction History
Rhenman & Partners Asset Management Ab
- $840 Million
- Q1 2025
A detailed history of Rhenman & Partners Asset Management Ab transactions in Dexcom Inc stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 155,000 shares of DXCM stock, worth $13.3 Million. This represents 1.26% of its overall portfolio holdings.
Number of Shares
155,000Holding current value
$13.3 Million% of portfolio
1.26%Shares
10 transactions
Others Institutions Holding DXCM
# of Institutions
1,082Shares Held
362MCall Options Held
5.4MPut Options Held
4.3M-
Vanguard Group Inc Valley Forge, PA47.5MShares$4.07 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.96 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.43 Billion0.05% of portfolio
-
Baillie Gifford & CO14.2MShares$1.22 Billion0.87% of portfolio
-
Capital Research Global Investors Los Angeles, CA12MShares$1.03 Billion0.19% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $33.1B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...